SNTG2
Gamma-2-syntrophin
Also known as: G2SYN, SNTG2_HUMAN, SYN5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NY99
- Gene
- SNTG2
- Ensembl
- ENSG00000172554
- Chromosome
- 2
- Canonical length
- 539 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
This gene encodes a protein belonging to the syntrophin family. Syntrophins are cytoplasmic peripheral membrane proteins that bind to components of mechanosenstive sodium channels and the extreme carboxy-terminal domain of dystrophin and dystrophin-related proteins. The PDZ domain of this protein product interacts with a protein component of a mechanosensitive sodium channel that affects channel gating. Absence or reduction of this protein product has been associated with Duchenne muscular dystrophy. There is evidence of alternative splicing yet the full-length nature of these variants has not been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
539 residues, UniProt reviewed canonical sequence.
>Q9NY99|SNTG2
1 MGTEGPPPPA ASRGRQGCLL VPARTKTTIA LLYDEESENA YDIRLKLTKE VLTIQKQDVV
61 CVGGSHQGRN RRTVTLRRQP VGGLGLSIKG GSEHNVPVVI SKIFEDQAAD QTGMLFVGDA
121 VLQVNGIHVE NATHEEVVHL LRNAGDEVTI TVEYLREAPA FLKLPLGSPG PSSDHSSGAS
181 SPLFDSGLHL NGNSSTTAPS SPSSPIAKDP RYEKRWLDTL SVPLSMARIS RYKAGTEKLR
241 WNAFEVLALD GVSSGILRFY TAQDGTDWLR AVSANIRELT LQNMKMANKC CSPSDQVVHM
301 GWVNEKLQGA DSSQTFRPKF LALKGPSFYV FSTPPVSTFD WVRAERTYHL CEVLFKVHKF
361 WLTEDCWLQA NLYLGLQDFD FEDQRPYCFS IVAGHGKSHV FNVELGSELA MWEKSFQRAT
421 FMEVQRTGSR TYMCSWQGEM LCFTVDFALG FTCFESKTKN VLWRFKFSQL KGSSDDGKTR
481 VKLLFQNLDT KQIETKELEF QDLRAVLHCI HSFIAAKVAS VDPGFMDSQS LARKYMYSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SNTG2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 3.1 nTPM
Expression across tissuesHPA
Tissue
- spleen: 3.1 nTPM
- pituitary gland: 2.8 nTPM
- adipose tissue: 1.9 nTPM
- retina: 1.9 nTPM
- breast: 1.8 nTPM
- testis: 1.7 nTPM
Single-cell type
- retinal horizontal cells: 1,238 nCPM
- corticotrophs: 614 nCPM
- lymphatic endothelial cells: 387 nCPM
- vascular endothelial cells: 326 nCPM
- choroid plexus epithelial cells: 323 nCPM
- somatotrophs: 287 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- cerebral cortex: 4.6 nTPM
- pons: 3.5 nTPM
- choroid plexus: 3.3 nTPM
- medulla oblongata: 3.2 nTPM
- cerebellum: 3.1 nTPM
- midbrain: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.19
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SNTG2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SNTG2 as an antibody target. Whether an autoantibody or antibody against SNTG2 could matter depends on whether native SNTG2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SNTG2 is annotated at the cell surface, where native SNTG2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SNTG2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...